Sep 2, 2022 · Get Free Access to the Data Below for 10 Ads! ZEPOSIA is a prescription medication intended to treat ulcerative colitis when taken as directed. Sasha Lester ... Daughter on the horse and at the airport. Have questions about this ad or …

Oct 20, 2022 · ZEPOSIA is a prescription medication intended to treat ulcerative colitis when taken as directed.

Jul 13, 2023 · Bristol Myers Squibb is launching a new ad for its blockbuster-in-waiting drug Zeposia as it focuses on a future for those with ulcerative colitis.

Feb 27, 2025 · Watch, interact and learn more about the songs, characters, and celebrities that appear in your favorite ZEPOSIA TV Commercials. Watch the commercial, share it with friends, then discover more great ZEPOSIA TV commercials on iSpot.tv.

Ozanimod, sold under the brand name Zeposia, is an immunomodulatory medication for the treatment of relapsing multiple sclerosis and ulcerative colitis. [ 3 ] [ 4 ] [ 6 ] [ 7 ] It acts as a sphingosine-1-phosphate receptor (S1PR) agonist, sequestering lymphocytes to peripheral lymphoid organs and away from their sites of chronic inflammation.

ZEPOSIA® (ozanimod) is a prescription medication for adults that treats moderate to severe UC and relapsing MS. See safety info and full Prescribing Information.

Jan 14, 2022 · “I won’t let UC stop me from being me,” says a handsome middle-aged father as he travels from the airport to the great outdoors in a fairly classic, no-frills advert for Zeposia, Bristol Myers...

Sep 6, 2024 · Zeposia (ozanimod) is used for the treatment of relapsing forms of multiple sclerosis (MS) and ulcerative colitis. Includes Zeposia side effects, warnings, and interactions.

Zeposia (ozanimod) is an oral medicine used to treat adults with relapsing forms of multiple sclerosis (MS). The specific forms of MS treated by Zeposia include active secondary progressive disease, relapsing-remitting disease, and clinically isolated syndrome. 1,2

May 27, 2021 · Bristol Myers Squibb is continuing to evaluate Zeposia in an open-label extension trial, which is ongoing and designed to assess the longer-term profile of Zeposia for the treatment of moderately to severely active ulcerative colitis.